Effect of Butea monosperma (Lamk.)Taub. (Palas papra) fruit on blood glucose and lipid profiles of normal and diabetic human volunteers

African Journal of Pharmacy and Pharmacology

Volumn 4, Issue 8, 2010, Pages 539-544

  Akhtar, Muhammad Shoaib ^a   Naeem, Fizza ^b   Muhammad, Faqir ^b   Bhatty, Nighat ^b  

^a UNIVERSITY OF SARGODHA   (Pakistan)

^b UNIVERSITY OF AGRICULTURE   (Pakistan)

Author keywords

Butea monosperma; Cholesterol; Diabetes; Humans; Lipids

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; BUTEA MONOSPERMA FRUIT POWDER; CARBOXYMETHYLCELLULOSE; GLIBENCLAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; PLANT MEDICINAL PRODUCT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BUTEA MONOSPERMA; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE COMPARISON; FRUIT; GLUCOSE BLOOD LEVEL; HUMAN; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; POWDER; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VOLUNTEER;

EID: 77958174962     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Akhtar MS (1995). Efficacy of some indigenous medicinal plants indiabetic patients. Proceedings of the 2nd Annual National Symposiumon Health Care and Social Development, The Aga Khan University,Karachi, Pakistan, 232-236.
2. Al-Rowais NA (2002). Herbal medicine in the treatment of diabetesmellitus. Saudi Med. J., 23: 1327-1331.
3. Charles B (1995). Cholesterol and its Health Hazards. New York.Stonesong Press.
4. Fried-Wald WT, Levy RI, Fredrickson DS (1972). Estimation of theconcentration of LDL-cholesterol in plasma without use of thepreparative ultracentrifuge. Clin. Chem., 18: 499-502.
5. He J, Klag MJ, Whelton PK, Mo JP, Chen JY, Qian MC, Mo PS, He GQ(1995). Oatbran intake selectively lower serum LDL-C concentrationof hypercholesterolemic men. Am. J. Chin. Nutr., 61: 366-372.
6. Hernandes DR, Hatcher LF, Pappu AS, Newcomb KC, Conner WE(1995). Role of dietary cholesterol in the optimal diet for the treatmentof hypercholesterolemia. Can. J. Cardiol., 11(6): 115-117.
7. Larner J (1985). Insulin and oral hypoglycaemic drugs; Glucagon. In:Gilman AG, Goodman LS, Rall TW, Murad F, (Eds.) 7th Ed.Macmillan, New York. Pharmacol. Basis Ther., pp 1490-1516.
8. Laurence DR, Bacharach AL (1964). Evaluation of drug activities:Pharmacometrics, Academic Press, London and New York (pp. 33-35).
9. Owen MR, Doran E, Halestrap AP (2000). Evidence that metforminexerts its anti-diabetic effects through inhibition of complex-1 of themitochondrial respiratory chain. Biochem. J., 15: 607-614.
10. Pedersen O, Hermenson K, Palmvig B, Pederson SE, Sondergaard K(1992). Dietary treatment of Diabetes mellitus: Background and rational for recommendations in 1990's. Ugskr Laeger, 154: 910-916.
11. Roberts CK, Vaziri ND, Barnard RJ (2002). Effect of diet and exerciseintervention on blood pressure, insulin, oxidative stress, and nitricoxide availability. Circulation, 12: 2530-2532.
12. Sammad AS (1993). Diabetes mellitus: A major health problem inPakistan. Pak. Med. J., 124: 15-18.
13. Somani R, Kasture S, Singhai AK (2006). Antidiabetic potential of Buteamonosperma in rats. Fitoterapia, 77: 86-90.
14. Vessby B, Karlstron B, Ohroall M, Jarvi A, Anderson A, Basu S (2000).Diet nutrition and diabetes mellitus, Upsala J. Med. Sci., 105: 151-60.
15. Wahlaquist MS (1997). Nutrition and diabetes, Awst Fam Physician, 26:284-289.
16. Wardlaw GM (1999). Perspective in Nutrition (4th Ed.). McGraw Hill,New York.WHO (1997). Obesity Preventing and Managing the Global Epidemic.Report of a WHO Expert Committee. Tech. Rep. Ser., 854: 368-369.
17. Wursch P, Pi-Sunyer FX (1997). The role of viscous soluble fiber in themetabolic control of diabetes. A review with special emphasis oncereal rich in beta glucan. DiabetesCare, 20(11): 1774-1780.